CRISPR THERAPEUTICS AG
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | — | -1,319.3% | -448.8% |
| FY2017 | — | -157.7% | -166.7% |
| FY2018 | — | -5,087.8% | -5,281.1% |
| FY2019 | — | 16.1% | 23.1% |
| FY2020 | — | -49,295.5% | -48,520.9% |
| FY2021 | — | 40.8% | 41.3% |
| FY2022 | — | -56,190.4% | -54,271.7% |
| FY2023 | — | -60.0% | -41.4% |
| FY2024 | — | -1,250.4% | -981.5% |
| FY2025 | — | -18,933.6% | -16,569.8% |